Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waters

Showing results (401-410 of 418) with videos related to

Pageof 42
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
Blood conservationMohammad R Rasouli, Luiz Sérgio Marcelino Gomes, Brian Parsley, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Vox Sanguinis|January 1, 1997
Management of alloimmunized, refractory patients in need of platelet transfusionsC P Engelfriet, H W Reesink, R H Aster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
NPJ Parkinson'S Disease|April 26, 2016
<i>SCARB2</i> variants and glucocerebrosidase activity in Parkinson's diseaseRoy N Alcalay, Oren A Levy, Pavlina Wolf, et al.
The Journal of Arthroplasty|December 24, 2013
Blood conservationMohammad R Rasouli, Luiz Sérgio Marcelino Gomes, Brian Parsley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 2020
Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's DiseaseEric Yu, Uladzislau Rudakou, Lynne Krohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura, Judit Matito, Mafalda Oliveira, et al.
Neurology. Genetics|February 12, 2020
Analysis of common and rare <i>VPS13C</i> variants in late-onset Parkinson diseaseUladzislau Rudakou, Jennifer A Ruskey, Lynne Krohn, et al.
Transfusion|December 9, 2024
Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert-based definition and criteria from the International HIT-OVER ForumD Fischer, M A Weigand, R Moss, et al.
Pageof 42

Showing results (401-410 of 418) with videos related to

Sort By:
Pageof 42
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
Blood conservationMohammad R Rasouli, Luiz Sérgio Marcelino Gomes, Brian Parsley, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Vox Sanguinis|January 1, 1997
Management of alloimmunized, refractory patients in need of platelet transfusionsC P Engelfriet, H W Reesink, R H Aster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
NPJ Parkinson'S Disease|April 26, 2016
<i>SCARB2</i> variants and glucocerebrosidase activity in Parkinson's diseaseRoy N Alcalay, Oren A Levy, Pavlina Wolf, et al.
The Journal of Arthroplasty|December 24, 2013
Blood conservationMohammad R Rasouli, Luiz Sérgio Marcelino Gomes, Brian Parsley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 2020
Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's DiseaseEric Yu, Uladzislau Rudakou, Lynne Krohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura, Judit Matito, Mafalda Oliveira, et al.
Neurology. Genetics|February 12, 2020
Analysis of common and rare <i>VPS13C</i> variants in late-onset Parkinson diseaseUladzislau Rudakou, Jennifer A Ruskey, Lynne Krohn, et al.
Transfusion|December 9, 2024
Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert-based definition and criteria from the International HIT-OVER ForumD Fischer, M A Weigand, R Moss, et al.
Pageof 42